JPML Creates MDL Docket for Contaminated Valsartan-Containing Drug Lawsuits



DOCUMENTS
  • Order


WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation has created a coordinated docket for lawsuits seeking economic and personal injury damages from the makers of valsartan-containing drugs that were contaminated with N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA).

In the Feb. 14 transfer order, the panel said the U.S. District Court for the District of New Jersey is an appropriate transferee district. Judge Robert B. Kugler will oversee the docket, which will presently include 40 related actions.

The panel said that since plaintiffs filed their motion for coordination or consolidation of 11 cases, it has been notified of 30 additional …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS



HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS